Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Market Cap	12.50B
Revenue (ttm)	4.21B
Net Income (ttm)	987.40M
Shares Out	84.72M
EPS (ttm)	11.61
PE Ratio	12.70
Forward PE	10.77
Dividend	7.50 (5.08%)
Ex-Dividend Date	Mar 26, 2025

Volume	163,546
Average Volume	404,350
Open	151.00
Previous Close	151.00
Day's Range	147.50 - 151.00
52-Week Range	133.00 - 244.50
Beta	0.23
RSI	47.65
Earnings Date	Nov 11, 2025

About TPEX:3218

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses fo...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3218

Financial Performance

In 2024, TPEX:3218's revenue was 4.23 billion, an increase of 3.58% compared to the previous year's 4.08 billion. Earnings were 1.06 billion, an increase of 1.88%.